Skip to main content
Journal cover image

To Treat or Not to Treat: Low-Dose Alteplase for Patients With Acute Ischemic Stroke Taking Direct Oral Anticoagulants Within 24 Hours.

Publication ,  Journal Article
Kam, W; Xian, Y
Published in: J Am Heart Assoc
October 4, 2022

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Am Heart Assoc

DOI

EISSN

2047-9980

Publication Date

October 4, 2022

Volume

11

Issue

19

Start / End Page

e027238

Location

England

Related Subject Headings

  • Treatment Outcome
  • Tissue Plasminogen Activator
  • Thrombolytic Therapy
  • Stroke
  • Ischemic Stroke
  • Humans
  • Fibrinolytic Agents
  • Brain Ischemia
  • Anticoagulants
  • 3201 Cardiovascular medicine and haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kam, W., & Xian, Y. (2022). To Treat or Not to Treat: Low-Dose Alteplase for Patients With Acute Ischemic Stroke Taking Direct Oral Anticoagulants Within 24 Hours. J Am Heart Assoc, 11(19), e027238. https://doi.org/10.1161/JAHA.122.027238
Kam, Wayneho, and Ying Xian. “To Treat or Not to Treat: Low-Dose Alteplase for Patients With Acute Ischemic Stroke Taking Direct Oral Anticoagulants Within 24 Hours.J Am Heart Assoc 11, no. 19 (October 4, 2022): e027238. https://doi.org/10.1161/JAHA.122.027238.
Kam, Wayneho, and Ying Xian. “To Treat or Not to Treat: Low-Dose Alteplase for Patients With Acute Ischemic Stroke Taking Direct Oral Anticoagulants Within 24 Hours.J Am Heart Assoc, vol. 11, no. 19, Oct. 2022, p. e027238. Pubmed, doi:10.1161/JAHA.122.027238.
Journal cover image

Published In

J Am Heart Assoc

DOI

EISSN

2047-9980

Publication Date

October 4, 2022

Volume

11

Issue

19

Start / End Page

e027238

Location

England

Related Subject Headings

  • Treatment Outcome
  • Tissue Plasminogen Activator
  • Thrombolytic Therapy
  • Stroke
  • Ischemic Stroke
  • Humans
  • Fibrinolytic Agents
  • Brain Ischemia
  • Anticoagulants
  • 3201 Cardiovascular medicine and haematology